ANTIBODIES TO OPGL
- 专利权人:
- Amgen Fremont Inc.
- 发明人:
- 申请号:
- NO2019048
- 公开号:
- NO2019048I1
- 申请日:
- 2019.12.20
- 申请国别(地区):
- NO
- 年份:
- 2019
- 代理人:
- 摘要:
- Antibodies that interact with osteoprotegerin ligand (OPGL) are described. Methods of treating osteopenic disorders by administering a pharmaceutically effective amount of antibodies to OPGL are described. Methods of detecting the amount of OPGL in a sample using antibodies to OPGL are described.
- 来源网站:
- 中国工程科技知识中心